Benzinga | Nov 4, 2021 08:27AM EDT

Akebia Therapeutics Q3 EPS $(0.34) Misses $(0.32) Estimate, Sales $48.76M Miss $49.67M Estimate

Akebia Therapeutics (NASDAQ:AKBA) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.32) by 6.25 percent. This is a 19.05 percent increase over losses of $(0.42) per share from the same period last year. The company reported quarterly sales of $48.76 million which missed the analyst consensus estimate of $49.67 million by 1.84 percent. This is a 18.72 percent decrease over sales of $59.99 million the same period last year.